Eventide Asset Management’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-190,000
| Closed | -$1.47M | – | 136 |
|
|
2016
Q4 | $1.47M | Hold |
190,000
| – | – | 0.1% | 101 |
|
|
2016
Q3 | $2.17M | Hold |
190,000
| – | – | 0.13% | 96 |
|
|
2016
Q2 | $2.34M | Hold |
190,000
| – | – | 0.14% | 96 |
|
|
2016
Q1 | $1.92M | Hold |
190,000
| – | – | 0.11% | 105 |
|
|
2015
Q4 | $4.28M | Buy |
190,000
+43,100
| +29% | +$972K | 0.21% | 93 |
|
|
2015
Q3 | $2.44M | Buy |
146,900
+61,800
| +73% | +$1.03M | 0.14% | 94 |
|
|
2015
Q2 | $1.92M | Hold |
85,100
| – | – | 0.1% | 98 |
|
|
2015
Q1 | $2.19M | Buy |
85,100
+32,300
| +61% | +$833K | 0.17% | 92 |
|
|
2014
Q4 | $1.15M | Hold |
52,800
| – | – | 0.13% | 95 |
|
|
2014
Q3 | $1M | Hold |
52,800
| – | – | 0.14% | 92 |
|
|
2014
Q2 | $1.23M | Hold |
52,800
| – | – | 0.17% | 93 |
|
|
2014
Q1 | $1.78M | Buy |
52,800
+30,300
| +135% | +$1.02M | 0.28% | 74 |
|
|
2013
Q4 | $664K | Buy |
+22,500
| New | +$664K | 0.2% | 72 |
|